Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLegend Biotech Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 4 | -$0.23 | -$0.11 | -$0.19 |
| Q2 2025 | 2 | -$0.15 | -$0.11 | -$0.13 |
| Q3 2025 | 2 | -$0.12 | -$0.09 | -$0.10 |
| Q4 2025 | 2 | -$0.04 | -$0.03 | -$0.03 |
| Q1 2026 | 1 | $0.13 | $0.17 | $0.15 |
| Q2 2026 | 1 | $0.21 | $0.28 | $0.24 |
| Q3 2026 | 1 | $0.30 | $0.41 | $0.35 |
| Q4 2026 | 1 | $0.37 | $0.50 | $0.43 |
Legend Biotech Corporation Earnings Date And Information
Legend Biotech Corporation last posted its earnings results on Tuesday, March 11th, 2025. The company reported $-0.15 earnings per share for the quarter, topping analysts' consensus estimates of $-0.39 by $0.24. The company had revenue of 186.52 M for the quarter and had revenue of 627.24 M for the year. Legend Biotech Corporation has generated $-1 earnings per share over the last year ($-0.97 diluted earnings per share) and currently has a price-to-earnings ratio of -19.69. Legend Biotech Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based on prior year's report dates.
Legend Biotech Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/11/2025 | Q4 2024 | -$0.39 | $0.00 | N/A | N/A | $186.52 M |
| 11/12/2024 | Q3 2024 | -$0.56 | $0.00 | N/A | $143.91 M | $160.21 M |
| 08/09/2024 | Q2 2024 | -$0.54 | -$0.10 | 0.44 | $125.25 M | $186.52 M |
| 05/13/2024 | Q1 2024 | -$0.29 | -$0.33 | -0.04 | N/A | $93.99 M |
| 03/11/2024 | Q4 2023 | -$0.70 | -$0.80 | -0.1 | N/A | $79.46 M |
| 11/20/2023 | Q3 2023 | -$0.56 | -$0.34 | 0.22 | $97.25 M | $96.01 M |
| 05/18/2023 | Q2 2023 | -$0.44 | -$1.14 | -0.7 | $56.64 M | $73.33 M |
| 03/30/2023 | Q1 2023 | N/A | -$0.68 | N/A | N/A | $36.34 M |
| 03/29/2023 | Q4 2022 | N/A | -$0.85 | N/A | N/A | $27.63 M |
| 09/29/2022 | Q3 2022 | N/A | -$0.27 | N/A | $32.34 M | $27.36 M |
| 06/01/2022 | Q2 2022 | -$0.37 | -$1.25 | -0.88 | $33.62 M | $11.97 M |
| 03/18/2022 | Q1 2022 | -$0.35 | -$0.27 | 0.08 | N/A | $40.83 M |
| 11/16/2021 | Q4 2021 | -$0.35 | -$0.60 | -0.25 | N/A | $39.00 M |
| 08/23/2021 | Q3 2021 | -$0.31 | -$0.87 | -0.56 | $7.83 M | $16.88 M |
| 05/18/2021 | Q2 2021 | -$0.35 | -$0.66 | -0.31 | $9.13 M | $20.23 M |
| 03/18/2021 | Q1 2021 | -$0.28 | -$0.61 | -0.33 | N/A | $13.68 M |
| 11/16/2020 | Q4 2020 | -$0.31 | -$0.44 | -0.13 | N/A | $40.78 M |
| 08/31/2020 | Q3 2020 | N/A | -$0.50 | N/A | $13.00 M | $11.75 M |
| 08/31/2020 | Q2 2020 | N/A | -$1.25 | N/A | $13.00 M | $11.60 M |
| 03/30/2020 | Q1 2020 | N/A | -$0.34 | N/A | N/A | $11.55 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Legend Biotech Corporation Earnings: FAQ's
Legend Biotech Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based offlast year's report dates.
In the previous quarter, Legend Biotech Corporation (:LEGN) reported $-0.15 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.39 by $0.24.
The conference call for Legend Biotech Corporation's latest earnings report can be listened to online.
The conference call transcript for Legend Biotech Corporation's latest earnings report can be read online.
Legend Biotech Corporation (:LEGN) has a recorded annual revenue of $627.24 M.
Legend Biotech Corporation (:LEGN) has a recorded net income of $-177,026,000.Legend Biotech Corporation has generated $-0.97 earnings per share over the last four quarters.
Legend Biotech Corporation (:LEGN) has a price-to-earnings ratio of -19.69 and price/earnings-to-growth ratio is -0.3.